Form 4: Johnson & Johnson Director Acquires Deferred Share Units
SEC Form 4 Filing
Director Marillyn A. Hewson acquired deferred share units (DSUs) of Johnson & Johnson, representing a deferral of cash retainer under the company's Amended and Restated Deferred Fee Plan for Directors.
Summary
- Marillyn A. Hewson, a director at Johnson & Johnson, acquired 334.523 deferred share units (DSUs) on December 10, 2024.
- These DSUs were acquired as a deferral of her cash retainer under the company's Amended and Restated Deferred Fee Plan for Directors.
- The DSUs will be settled in cash upon termination of her directorship.
- Each DSU represents the fair market value of one share of Johnson & Johnson common stock on the business day prior to the settlement date.
- The acquisition price of the DSUs was $149.67 per unit.
- Hewson now holds a total of 11,380.2237 DSUs, including dividend equivalent rights.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral to positive. The acquisition of DSUs aligns the director's interests with the company's long-term performance.
Positives
- The acquisition of DSUs aligns the director's interests with the long-term performance of the company.
- The deferral of cash retainer into DSUs demonstrates a commitment to the company's future.
Future Outlook
The DSUs will be settled in cash upon termination of the Reporting Person's directorship.
Industry Context
This is a routine filing related to director compensation and is common practice for publicly traded companies.
Comparison to Industry Standards
- Deferred share unit grants are a common form of compensation for directors in large publicly traded companies like Johnson & Johnson.
- Many companies in the pharmaceutical and healthcare sector use similar deferred compensation plans to align director interests with shareholder value.
- The structure of the DSU plan, with settlement in cash upon termination of directorship, is a standard practice.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 12/10/2024 | Date of the transaction where Marillyn A. Hewson acquired deferred share units. |
| 12/12/2024 | Date the Form 4 was signed. |
Keywords
Deferred Share Units, DSU, Director, Johnson & Johnson, JNJ, Insider Transaction, Form 4, Share Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.